'Half of the $18.7bn spent on R&D to tackle priority diseases between 2014 and 2022 was provided by the US government. The reliance on US funding was a “major vulnerability” that leaves pandemic preparedness “very sensitive” to political upheavals, the 100 Days Mission report said.'

https://www.ft.com/content/b2cc3bef-926b-44a2-b948-d7156c62e405